Related Experiment Video
Updated: May 30, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells
Daniele Vergara1, Concetta Maria Valente, Andrea Tinelli
1Laboratory of General Physiology, Department of Biological and Environmental Sciences and Technologies, University of Salento, via Monteroni 73100, Lecce, Italy.
Abstract:
Carcinoma progression is associated with the loss of epithelial features, and the acquisition of a mesenchymal phenotype by tumour cells. Herein we show that exposure of MCF-7 cells to epidermal growth factor (EGF) resulted in morphological alterations characteristic of epithelial-to-mesenchymal transition (EMT). EGF treatment resulted in increased motility along with an up-regulation of transcription factors Slug, Zeb1, Zeb2, and mesenchymal markers Vimentin and N-cadherin. Treatment of MCF-7 cells with a combined stimulation of EGF and resveratrol, a naturally occurring stilbene with antitumor properties, failed to alter cell morphology, motility and overexpression of EMT markers induced by EGF. Using specific chemical inhibitors, we demonstrated that EGF-induced EMT is mediated by extracellular signal-regulated kinase 1/2 (ERK 1/2) signalling pathway and that resveratrol is able to repress EGF-induced ERK activation. In summary, these data provide new evidence of the inhibitory effect of resveratrol on EGF-induced EMT cell transformation.
Insights
Resveratrol inhibits epidermal growth factor (EGF)-induced epithelial-to-mesenchymal transition (EMT) in MCF-7 cells. This natural compound blocks EGF’s effects on cell morphology, motility, and key EMT markers by inhibiting the ERK signaling pathway.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Carcinoma progression involves the loss of epithelial characteristics and the gain of a mesenchymal phenotype, a process known as epithelial-to-mesenchymal transition (EMT).
- Epidermal growth factor (EGF) is a known inducer of EMT in various cancer cells.
- Resveratrol, a natural stilbene, exhibits potential antitumor properties.
Purpose of the Study:
- To investigate the effect of EGF on inducing EMT in MCF-7 cells.
- To determine whether resveratrol can inhibit EGF-induced EMT.
- To elucidate the signaling pathway involved in EGF-induced EMT and resveratrol's inhibitory mechanism.
Main Methods:
- MCF-7 cells were treated with EGF alone or in combination with resveratrol.
- Morphological changes, cell motility, and expression of EMT markers (Slug, Zeb1, Zeb2, Vimentin, N-cadherin) were assessed.
- Specific chemical inhibitors were used to identify the involvement of the extracellular signal-regulated kinase 1/2 (ERK 1/2) pathway.
Main Results:
- EGF treatment induced morphological changes, increased motility, and upregulated EMT markers in MCF-7 cells.
- Combined treatment with EGF and resveratrol did not alter EGF-induced EMT.
- EGF-induced EMT was mediated by the ERK 1/2 signaling pathway.
- Resveratrol effectively repressed EGF-induced ERK activation.
Conclusions:
- EGF induces EMT in MCF-7 cells via the ERK 1/2 signaling pathway.
- Resveratrol inhibits EGF-induced EMT by repressing ERK 1/2 activation.
- These findings highlight resveratrol's potential as an inhibitor of cancer cell transformation and progression.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Mitogens and the Cell Cycle
Renewal of Skin Epidermal Stem Cells
Mesenchymal Stem Cells
Clinical Applications of Epidermal Stem Cells
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

